Press release
Liver Fibrosis Drugs Market Size 2032 | Inventiva Pharma, Galmed Research and Development, Ltd., Madrigal Pharmaceuticals, Inc., Intercept Pharmaceuticals, Galectin Therapeutics Inc., Zydus Therapeutics, Axcella Therapeutics, Akero Therapeutics, Inc, Lipo
Liver Fibrosis Drugs Market
Key Takeaways from the Liver Fibrosis Market Report
• The increase in Liver Fibrosis Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Liver Fibrosis Market is anticipated to witness growth at a considerable CAGR.
• In the assessment done by DelveInsight, the estimated total liver fibrosis diagnosed prevalent cases in the 7MM were 19,126,579 in 2021.
• The highest diagnosed prevalent cases of Liver fibrosis were accounted by the US in 2021 (9,488,135 cases), which are expected to show a rise in the future.
• The leading Liver Fibrosis Companies working in the market include Inventiva Pharma, Galmed Research and Development, Ltd., Madrigal Pharmaceuticals, Inc., Intercept Pharmaceuticals, Galectin Therapeutics Inc., Zydus Therapeutics, Axcella Therapeutics, Akero Therapeutics, Inc, Lipocine Inc., Enyo Pharma, Sagimet Biosciences Inc., 89bio Inc., HighTide Biopharma, Rivus Pharmaceuticals Inc, Novo Nordisk A/S, and others.
• Promising Liver Fibrosis Therapies in the various stages of development includes ND-L02-s0201 Injection, Hydronidone capsules, Simtuzumab, Aramchol, 68Ga-FAP-2286, and others.
Discover which therapies are expected to grab the Liver Fibrosis Market Share @ Liver Fibrosis Market Outlook- https://www.delveinsight.com/sample-request/liver-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Liver Fibrosis Overview
Liver fibrosis is a condition characterized by the excessive accumulation of scar tissue in the liver. This scarring occurs as a result of chronic damage to the liver, often from conditions such as chronic hepatitis B or C infection, excessive alcohol consumption, non-alcoholic fatty liver disease (NAFLD), or other causes of liver injury.
Liver Fibrosis Epidemiology Insights
The epidemiology section of Liver Fibrosis offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
• Total Diagnosed Prevalent cases
• Severity-specific Diagnosed cases
• Total Diagnosed Prevalent cases
Download the report to understand which factors are driving Liver Fibrosis Epidemiology trends @ Liver Fibrosis Epidemiological Insights- https://www.delveinsight.com/sample-request/liver-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Liver Fibrosis Drugs Market
The Liver Fibrosis Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Liver Fibrosis signaling in Liver Fibrosis are likely to uncover new therapeutic targets and further expand treatment options for patients.
Liver Fibrosis Treatment Market Landscape
The Liver Fibrosis treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Liver Fibrosis has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Liver Fibrosis treatment guidelines, visit @ Liver Fibrosis Treatment Market Landscape- https://www.delveinsight.com/sample-request/liver-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Liver Fibrosis Market Outlook
The report's outlook on the Liver Fibrosis market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Liver Fibrosis therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Liver Fibrosis drug and late-stage pipeline therapy.
It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Liver Fibrosis market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.
Liver Fibrosis Drugs Uptake
The drug chapter of the Liver Fibrosis report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Liver Fibrosis.
Major Liver Fibrosis Companies
Inventiva Pharma, Galmed Research and Development, Ltd., Madrigal Pharmaceuticals, Inc., Intercept Pharmaceuticals, Galectin Therapeutics Inc., Zydus Therapeutics, Axcella Therapeutics, Akero Therapeutics, Inc, Lipocine Inc., Enyo Pharma, Sagimet Biosciences Inc., 89bio Inc., HighTide Biopharma, Rivus Pharmaceuticals Inc, Novo Nordisk A/S, and others.
Learn more about the FDA-approved drugs for Liver Fibrosis @ Drugs for Liver Fibrosis Treatment- https://www.delveinsight.com/sample-request/liver-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Liver Fibrosis Market Report
• Coverage- 7MM
• Liver Fibrosis Companies- Inventiva Pharma, Galmed Research and Development, Ltd., Madrigal Pharmaceuticals, Inc., Intercept Pharmaceuticals, Galectin Therapeutics Inc., Zydus Therapeutics, Axcella Therapeutics, Akero Therapeutics, Inc, Lipocine Inc., Enyo Pharma, Sagimet Biosciences Inc., 89bio Inc., HighTide Biopharma, Rivus Pharmaceuticals Inc, Novo Nordisk A/S, and others.
• Liver Fibrosis Therapies- ND-L02-s0201 Injection, Hydronidone capsules, Simtuzumab, Aramchol, 68Ga-FAP-2286, and others.
• Liver Fibrosis Market Dynamics: Liver Fibrosis Market Drivers and Barriers
• Liver Fibrosis Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Liver Fibrosis Drugs in development @ Liver Fibrosis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/liver-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Report Introduction
3. Liver Fibrosis Market Overview at a Glance
4. Liver Fibrosis Market: Future Perspective
5. Executive Summary of Liver Fibrosis
6. Key Events
7. Disease Background and Overview: Liver Fibrosis
8. Epidemiology and Patient Population
9. Patient Journey
10 .Emerging Drugs
11. Liver Fibrosis: Seven Major Market Analysis
12. Key Opinion Leaders' Views
13. Market Drivers
14. Market Barriers
15. SWOT Analysis
16. Unmet Needs
17. Reimbursement and Market Access
18. Appendix
19. Report Methodology
20. DelveInsight Capabilities
21. Disclaimer
22. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Yash Bhardwaj
info@delveinsight.com
+91-9650213330
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liver Fibrosis Drugs Market Size 2032 | Inventiva Pharma, Galmed Research and Development, Ltd., Madrigal Pharmaceuticals, Inc., Intercept Pharmaceuticals, Galectin Therapeutics Inc., Zydus Therapeutics, Axcella Therapeutics, Akero Therapeutics, Inc, Lipo here
News-ID: 3611418 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Liver
Rising Liver Disease Cases Drive Growth In Liver Metastases Treatment Market Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Liver Metastases Treatment Market Size By 2025?
The market for treating liver metastases has seen significant growth in the past few years. It is projected to increase from $1.57 billion in 2024 to $1.71 billion in 2025, with a compound annual growth rate (CAGR) of…
LivCare Liver Support
The liver plays a crucial role in maintaining overall well-being, performing essential functions like detoxification, digestion, and metabolism. However, many people overlook the importance of liver health until problems arise. LivCare Liver Support is a premium supplement designed to keep your liver in peak condition. By incorporating this supplement into your daily routine, you can help ensure your liver functions optimally, leading to better overall health.
● Product Name - LivCare…
Liver Cancer Therapeutics Market - Empowering Recovery, Restoring Health: Innova …
Newark, New Castle, USA - new report, titled Liver Cancer Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liver Cancer Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liver Cancer Therapeutics market. The report offers an overview of…
Liver Health Supplements Market Grows Strong as Consumers Adopt Proactive Measur …
Global liver health supplements market was valued at US$ 8.7 Bn in 2021, is growing at an estimated CAGR of 5.8% over the forecast period (2022 - 2030). The liver health supplements market is growing due to the increasing awareness of the importance of liver health and the rise of lifestyle-related liver diseases. The market offers a wide range of supplements that help in improving liver function, supporting liver detoxification,…
Urgent Liver 911 Reviews 2021: Is Urgent Liver 911 Legit?
Urgent Liver 911 by PhytAge Laboratories is a powerful diet that promotes liver function by combining natural minerals and nutrients. The diet is made up of plant and herbal extracts that collectively aid in liver cell protection. While the liver is an important human organ that promotes general health and vitality, most people are unaware that even those who appear to be in good health can be affected by liver…
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production…
